- US Centers for Disease Control and Prevention
- Infusion Nurses Society
- Society for Healthcare Epidemiology of America
- The Joint Commission National Patient Safety Goals
- Infectious Diseases Society of America
- Association for Professionals in Infection Control and Epidemiology
- Association for Vascular Access
- 14 independent clinical studies demonstrating clinical efficacy of Prevantics® products.
Frequently Asked Questions
Q Do I need to wipe off the Prevantics® antiseptic liquid from the skin after application?
No. Prevantics products contain 3.15% Chlorhexidine Gluconate (CHG) and 70% Isopropyl Alcohol (IPA) which should be left on the skin to provide continued antimicrobial activity.
Q Why are Prevantics® Skin Antiseptics applied using back and forth strokes?
The back and forth strokes provide friction which allows for deeper penetration of the antiseptic into the cracks and fissures of the skin in the epidermis.
Q What is the difference between an occlusive and semi-occlusive dressing?
An occlusive dressing is a non-permeable dressing, which means that no air or moisture can penetrate in or out. A semi-occlusive (semi-permeable, transparent) dressing allows the wound to “breathe” (air can penetrate in and out) but at the same time, protects the wound from outside liquids. Commonly used dressings in vascular access are semi-occlusive, transparent dressings.
Q What are considered “dry” sites and “wet” sites?
Dry sites are areas where there are no skin folds, such as the abdomen and forearm, and no evidence of moisture caused by diaphoresis. Wet sites are areas with skin folds, such as the groin area, under arms, and under breasts, as well as areas that may be moist due to diaphoresis.